Showing results (301-310 of 439) with videos related to

Sort By:
Pageof 44
The American Journal of Cardiology|June 1, 1983
Intracoronary thrombolysis in acute myocardial infarction: an attempt to quantitate its effect by comparison of enzymatic estimate of myocardial necrosis with left ventricular ejection fractionF Schwarz, A Faure, H Katus, et al.
The American Journal of Cardiology|November 1, 1982
Intracoronary thrombolysis in acute myocardial infarction: duration of ischemia as a major determinant of late results after recanalizationF Schwarz, G Schuler, H Katus, et al.
Human Pathology|October 1, 1990
"Intravascular lymphomatosis" (angioendotheliomatosis): evidence for a T-cell origin in two casesN Sepp, G Schuler, N Romani, et al.
Heart (British Cardiac Society)|July 23, 2014
Prognostic significance and relationship of worst lead residual ST segment elevation with myocardial damage assessed by cardiovascular MRI in myocardial infarctionK P Rommel, A Baum, M Mende, et al.
The American Journal of Cardiology|October 1, 1994
Identification of patients at risk during swimming by Holter monitoringJ Niebauer, R Hambrecht, K Hauer, et al.
The Journal of Experimental Medicine|December 19, 2001
The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cellsM Lechmann, D J Krooshoop, D Dudziak, et al.
The Journal of Experimental Medicine|May 1, 1992
Identification of proliferating dendritic cell precursors in mouse bloodK Inaba, R M Steinman, M W Pack, et al.
Genes, Chromosomes & Cancer|November 20, 1997
Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell responseB Eibl, S Ebner, C Duba, et al.
Zeitschrift Fur Kardiologie|August 25, 2000
[Late diagnosis of Curschmann-Steinert myotonic dystrophy in a female patient with dilated cardiomyopathy and in her son]O Gunkel, H Reichenbach, B Thamm, et al.
Circulation|March 1, 1990
Intravenous thrombolytic therapy with a combination of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator in acute myocardial infarctionC Bode, G Schuler, T Nordt, et al.
Pageof 44